Source and scope
This summary is bounded to the recommendations, population and decisions covered by Canadian best practice recommendations for the management of amyotrophic lateral sclerosis. Apply it with the current provincial or territorial pathway where implementation differs.
sources for this section:CMAJ ALS
Source-attributed clinical priorities
- Refer progressive mixed upper- and lower-motor-neuron features urgently to a multidisciplinary ALS clinic.
- Monitor respiratory, bulbar, nutritional, communication, mobility and cognitive or behavioural needs proactively.
- Discuss disease-modifying treatment, symptom care and advance planning early while preserving patient choice.
- Do not delay referral while completing every mimic investigation when progressive motor-neuron signs are present.
sources for this section:CMAJ ALS
Practical assessment and management workflow
1
Document progression by region, upper and lower motor signs, bulbar symptoms, weight and respiratory complaints.
2
Assess spirometry or other respiratory measures, swallowing, nutrition, communication and mobility early.
3
Coordinate disease-modifying therapy eligibility and symptom treatment through a multidisciplinary ALS clinic.
4
Revisit equipment, caregiver support, ventilation, feeding and advance-care preferences before crises develop.
sources for this section:CMAJ ALS
Safety, red flags and urgent escalation
- Orthopnea, weak cough, aspiration, rapid weight loss or declining respiratory measures needs urgent ALS-team review.
- Avoid supplemental oxygen alone for neuromuscular hypoventilation without ventilation assessment.
- Do not assume cognition is preserved; screen for behavioural and frontotemporal change when decisions are affected.
sources for this section:CMAJ ALS
Confirm the local pathway before acting
The evidence source is pan-Canadian, but formularies, funded access, referral routes, public-health directions and service availability remain provincial or territorial.
sources for this section:CMAJ ALS
Source and implementation boundary
Read this educational summary with the linked source, current Canadian product information where medicines are involved, and the applicable provincial or territorial pathway. Local formularies, reporting duties, referral routes and service availability can differ.
sources for this section:CMAJ ALS
Source documents
Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.
- Canadian Medical Association JournalCanadian best practice recommendations for the management of amyotrophic lateral sclerosisaccessed 2026-08-20view source
continue the learning
From guidance to deliberate practice and evidence
Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.
Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the Canada question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.